ProMore Pharma
Founded Year
2002Stage
IPO | IPODate of IPO
7/6/2017About ProMore Pharma
Promore Pharma is a biopharmaceutical company specialized in the development of therapeutic peptides for the bioactive wound care market. The company has two therapeutic peptides, PXL01 and LL-37, in late stage clinical phase, and its vision is to provide medical aid for patients with large unmet medical requirements through development of products that enhance and accelerate natural healing processes in the body. Promore Pharma is headquartered at the Karolinska Institutet Science Park in Solna, Sweden.
Missing: ProMore Pharma's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: ProMore Pharma's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
ProMore Pharma Patents
ProMore Pharma has filed 3 patents.
The 3 most popular patent topics include:
- Diabetes
- Glucocorticoids
- Medical treatments
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
6/4/2020 | 12/7/2021 | Diabetes, Rare diseases, Vascular diseases, Glucocorticoids, Medical treatments | Grant |
Application Date | 6/4/2020 |
|---|---|
Grant Date | 12/7/2021 |
Title | |
Related Topics | Diabetes, Rare diseases, Vascular diseases, Glucocorticoids, Medical treatments |
Status | Grant |
Latest ProMore Pharma News
Jan 10, 2023
Promore Pharma Tue, Jan 10, 2023 09:30 CET For Solna-based Promore Pharma, 2022 was characterised by steady advancement in the development of its drug candidate ensereptide. During the year, the company carried out a significant part of a phase II study with the candidate, which is being developed to inhibit scarring on the skin. At the same time, preparations for phase III studies are ongoing for the second candidate, ropocamptide. BioStock contacted CEO Jonas Ekblom to find out more about the company’s goals for 2023. Read the article at biostock.se:
ProMore Pharma Frequently Asked Questions (FAQ)
When was ProMore Pharma founded?
ProMore Pharma was founded in 2002.
Where is ProMore Pharma's headquarters?
ProMore Pharma's headquarters is located at Karolinska Institutet Science Park, Solna.
What is ProMore Pharma's latest funding round?
ProMore Pharma's latest funding round is IPO.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.